Drug intelligence / Profile preview

cyclocarya paliurus polysaccharide

Development stage
Preclinical
Administration
Oral
01

Overview

Cyclocarya paliurus polysaccharide (CPP) is a bioactive macromolecule extracted from the leaves of *Cyclocarya paliurus*, a plant species endemic to China commonly known as the sweet tea tree. CPPs are recognized for their significant immunomodulatory, antioxidant, and anti-inflammatory properties. In preclinical models of ulcerative colitis, CPPs—particularly in their phosphorylated form (P-CPPs)—have demonstrated the ability to preserve intestinal barrier integrity by upregulating the expression of key proteins such as Mucin-2 (MUC-2), occludin, and claudin-1. The mechanism of action involves the suppression of pro-inflammatory signaling pathways, specifically the NF-κB pathway and NLRP3 inflammasome activation, which leads to a reduction in pro-inflammatory cytokines like TNF-α and IL-6. Additionally, CPPs modulate gut microbiota composition and metabolic activity, resulting in increased microbial diversity and elevated levels of short-chain fatty acids (SCFAs).

Other names
Cyclocarya paliurus polysaccharidesphosphorylated Cyclocarya paliurus polysaccharidesCPP
02

Targets

FFAR2AHR (Aryl hydrocarbon receptor)TLR4 (Toll-like receptor 4)

Beyond the preview

Go deeper on cyclocarya paliurus polysaccharide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cyclocarya paliurus polysaccharide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call